Steve Martin
2017 - AmpliPhi Biosciences
In 2017, Steve Martin earned a total compensation of $647.5K as Senior VP and Chief Financial Officer at AmpliPhi Biosciences, a 5% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $173,409 |
|---|---|
| Option Awards | $154,072 |
| Salary | $320,000 |
| Total | $647,481 |
Martin received $320K in salary, accounting for 49% of the total pay in 2017.
Martin also received $173.4K in non-equity incentive plan and $154.1K in option awards.
Rankings
In 2017, Steve Martin's compensation ranked 10,921st out of 14,666 executives tracked by ExecPay. In other words, Martin earned more than 25.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,921 out of 14,666 | 26th |
Division Manufacturing | 4,261 out of 5,772 | 26th |
Major group Chemicals And Allied Products | 1,531 out of 2,075 | 26th |
Industry group Drugs | 1,254 out of 1,731 | 28th |
Industry Biological Products, Except Diagnostic Substances | 227 out of 313 | 28th |
Source: SEC filing on November 9, 2018.
Martin's colleagues
We found five more compensation records of executives who worked with Steve Martin at AmpliPhi Biosciences in 2017.
2017
Igor Bilinsky
AmpliPhi Biosciences
Chief Operating Officer
2017
Igor Bilinsky
AmpliPhi Biosciences
Chief Operating Officer
2017
Michael Salka
AmpliPhi Biosciences
Chief Executive Officer
2017
Paul Grint
AmpliPhi Biosciences
Chief Executive Officer
2017
Paul Grint
AmpliPhi Biosciences